SPRINGNCT04480853
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 19 versions: 14 with changes below, 5 re-verified with no change. See every version on ClinicalTrials.gov ↗
Minor Enrollment closed, study ongoing Show 5 more changesShow less
- Trial sites reduced: 6 → 3 locations
- Final enrollment: 14 participants (planned 30)
- Primary completion date changed from estimate of Sep 30, 2027 to Oct 15, 2026
- Eligibility criteria expanded, about 10 words
- Secondary endpoints: details revised at 3 of 3 entries
- Minor Site details revised at 1 of 6 sitesv15
- Notable Primary and study completion dates: Jan 27, 2026 to Sep 30, 2027
- Site details revised at 2 of 6 sites
- Minor Site details revised at 2 of 6 sitesv12
- Notable Primary and study completion dates: Feb 28, 2025 to Jan 27, 2026v11
Show 8 earlier versionsHide 8 earlier versions
- Minor Site details revised at 1 of 6 sitesv10
- Notable Primary and study completion dates pushed to Feb 28, 2025
- Study sites: 5 to 6
- Notable Primary completion date: Jul 15, 2022 to Jul 15, 2024
- Study completion date: Jul 15, 2022 to Oct 15, 2024
- Minor Study sites: 4 to 5v6
- Minor Study sites: 1 to 4v5
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Minor Start date: Sep 15, 2020 to Oct 12, 2020v3
- Notable Start date: Aug 14, 2020 to Sep 15, 2020
- Eligibility criteria revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Number of Adverse Events of Special Interest(AESI)
Timeframe: First Dose Observation on the first day of taking findolimod
Number of Adverse Events of Special Interest (AESI)
Timeframe: Baseline up to 12 months
Secondary (3)
Annualized relapse reate (ARR)
Change from baseline of Pulse (beats/min)
Change from baseline of blood pressure (mmHg)
Arms and interventions
FingolimodExperimental
Open label Fingolimod 0.5 mg capsule taken once daily, oral.
Drugs: Fingolimod
Sites
3 sites in 1 country